The anti-VLA-4 antibody natalizumab induces erythroblastaemia in the majority of the treated patients with multiple sclerosis.

Research output: Contribution to journal › Research article

7 Citations (Web of Science)

Branches of science

@article{1474ca1831164cac8eda226089d778b8,

title = "The anti-VLA-4 antibody natalizumab induces erythroblastaemia in the majority of the treated patients with multiple sclerosis.",

author = "Christoph Robier and O Amouzadeh-Ghadikolai and C Bregant and J Diez and K Melinz and M Neubauer and Stefan Quasthoff",

year = "2014",

doi = "10.1177/1352458514521307",

language = "English",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - The anti-VLA-4 antibody natalizumab induces erythroblastaemia in the majority of the treated patients with multiple sclerosis.

AU - Amouzadeh-Ghadikolai, O

AU - Bregant, C

AU - Diez, J

AU - Melinz, K

AU - Neubauer, M

A2 - Robier, Christoph

A2 - Quasthoff, Stefan

PY - 2014

Y1 - 2014

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000340129500018

UR - https://pubmed.ncbi.nlm.nih.gov/24493472

U2 - 10.1177/1352458514521307

DO - 10.1177/1352458514521307

M3 - Research article

C2 - 24493472

SN - 1352-4585

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

ER -